The findings could help shorten hospital stays for cancer patients.

By raising awareness about the correlation between increased radiation exposure and cardiac events, average doses were reduced without minimizing cancer treatment. 

Findings suggest this method could provide data about tumors sooner than MRIs alone.

The trial advances basic science research on the relationship between purine levels and treatment resistance to develop new treatment options for patients.

The anti-cancer effect of the drug may help those with rare, hereditary cancer syndromes avoid surgeries by shrinking tumors via a daily oral dose.

In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.

The effort by the Michigan Radiation Oncology Quality Consortium reduced unnecessary medical procedures, and saved the time and resources of patients and families.

Why you should consider participating in a clinical trial and what to expect from the experience.

Clinical guidelines have encouraged the integration of palliative care, yet medicine lags far behind its goals for ovarian cancer, especially for people of color

Despite living with an adenoid cystic carcinoma, Celina Pitt finds joy in nightly dance parties with her husband.

The new approach blocks the interaction between cancer cells and immune receptors, showing promise in mice.

Patients with cancers of unknown origin greatly benefited from next-generation sequencing; widespread inherited cancer risk also suggests broad utility, a study finds.

A urologic oncology fellow dedicates his career to debunking false notions about racial biology.

From early stage colon cancer to advanced metastatic disease, Jennifer Watson’s cancer journey illustrates the importance of advocating for your health and partnering with a care team you trust.

Facing a challenging diagnosis of metastatic urologic cancer, one of the state’s top communications professionals leans into her job, laughter and love.